Global Lutein Market Is Estimated To Witness High Growth Due To Rising Popularity Of Natural Products And Increasing Change In Consumer Preferences

Lutein Market
Lutein Market

Overview:

Lutein is one of the two major carotenoids found as a color pigment in the human eye (macula and retina). It is thought to function as a light filter, protecting the eye tissues from sunlight damage. Increased lutein intake may decrease the risk of cataracts and age-related macular degeneration, a disease that leads to vision loss in older adults. It also helps reduce the symptoms of diabetic retinopathy, a disease that affects about one-third of people who have diabetes.

Recent research suggests that lutein supplements can help slow down the progression of some forms of dementia, such as Alzheimer’s and Parkinson’s disease. Moreover, researchers have also shown that dietary factors containing lutein can improve cognitive performance in elderly patients. It has been shown that lutein can improve osteoporosis by stimulating bone formation and preventing bone loss through its regulation of NF-kB. Lutein is a potent antioxidant, it can also protect against oxidative stress, which is an underlying cause of many chronic diseases.

Market Dynamics:

Rising product launches are estimated to augment growth of the global Lutein Market over the forecast period. For instance, in September 2021, OmniActive Health Technologies declared the launch of a proprietary combination of ingredients Nutritears. This product helps in addressing occasional dry eyes and it consists of curcuminoids, lutein, zeaxanthin isomers, and vitamin D3. Moreover, increasing side effects are anticipated to restrain growth of the global lutein for market over the forecast period.

Impact of COVID-19:

The pandemic was first reported in 2019 in China and later on it was transmitted to other countries. Several nations like Spain, Italy, France, India, Australis and many more imposed strict lockdowns for preventing the spread of the virus. The pandemic affected the growth of several business, many people lost their jobs and several companies switched to working remotely.

However, the pandemic also made people more conscious of their health and well-being. Many clinic were shut down during the pandemic and all doctors were deployed to attend to COVID-19 patients. This hampered the growth of the global Lutein Market. As many other treatments were post ponded during the pandemic. However, the market is estimated to witness growth as several restrictions have been eased.

Key Takeaways:

The global Lutein Market is expected to witness high growth, exhibiting CAGR of 6.3 % over the forecast period, due to increasing research and developmental activities.

For instance, Kemin Industries, launched a USDA-certified organic additive KEM GLO. Organic KEM GLO, in March, 2021. This additive helps in intensifying the color of egg yolks for organic egg producers.

North America is anticipated to witness significant growth in the global lutein for market over the forecast period, owing to growing urbanization and increasing industrialization.

Major players operating in the global Lutein Market are OmniActive Health Technologies, Kemin Industries, Inc., Allied Biotech Corporation, BASF SE, FENCHEM, Synthite Industries Ltd, LycoRed Ltd., Döhler Group, Divi's Nutraceuticals, Digestive Disease Week, Allied Biotech Corporation, NutraMarks, Inc., Vitae Caps S.A., Nature’s Bounty., PIVEG, INC., Döhler Group, Chenguang Biotech Group Co., Ltd, and KATRA GROUP.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more